Trials / Active Not Recruiting
Active Not RecruitingNCT00165256
Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast
Wide Excision Alone for DCIS-Grades 1 and 2
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 158 (actual)
- Sponsor
- Dana-Farber Cancer Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if wide excision (surgical removal) alone is adequate treatment for small, grade 1 or 2 ductal carcinoma in situ (DCIS) of the breast.
Detailed description
* Patients with DCIS are usually treated with the combination of breast-conserving surgery and radiation therapy or breast-conserving surgery alone. The purpose of this study is to evaluate whether localized low- or intermediate-grade DCIS, diagnosed with modern mammography and careful pathologic evaluation, could be treated with wide excision alone (omission of radiation therapy) and result in acceptably low local recurrence rates. * Follow-up consists of physical examinations at least every 6 months by the surgeon or radiation oncologist. Mammograms of the affected breast will be obtained every 6 months for 5 years and then annually. Mammograms of the unaffected breast will be performed annually.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observation | Wide excision of DCIS and a minimum of 1cm histologically negative margin of breast tissue |
Timeline
- Start date
- 1995-05-01
- Primary completion
- 2002-07-01
- Completion
- 2027-12-01
- First posted
- 2005-09-14
- Last updated
- 2025-12-29
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00165256. Inclusion in this directory is not an endorsement.